Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial

Authors: F Cosentino, C P Cannon, D Z I Cherney, S Dagogo-Jack, R E Pratley, B Charbonnel, W J Shih, J P Mancuso, M Maldonado, R Frederich, N B Cater, S Wang, D K McGuire

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.2650

Source: Full article

Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial

Abstract